We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
KOL KNOCKOUT™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease – Round 3
April 08, 2024
08:00 PM - 09:30 PM EDT
Malini Gupta, MD, ECNU, FACE
Kaniksha Desai, MD, ECNU, FACE
Sonalika Khachikian, MD
John Woody Sistrunk, MD
Ultrasound Renal Denervation: Interdisciplinary Approach to Better Patient Outcomes
Naomi Fisher, MD
Florian Rader, MD
It’s All About Patient Identification
Renuka Jain, MD
Unlocking the Potential of HER2-Targeted Therapy: Breakthroughs in NSCLC Therapeutic Approaches
Helena Yu, MD
The Latest Insights into Rare Blood Disorders: Diagnosis and Treatment Strategies
David J. Kuter, MD, DPhil
Spero R. Cataland, MD
Catherine Broome, MD
Cindy Neunert, MD, MSCS
Patient-Centric Approaches to Managing Migraines in the Female Patient
Jessica Ailani, MD
Dawn C. Buse, PhD
Clinical Challenges With Triple-Class or Penta-Refractory MM
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Putting Data into Clinical Practice
Pam R. Taub, MD, FACC, FASPC
Steven Yakubov, MD, MSCAI, FACC
Step-Up Dosing of Bispecific Antibodies: The Need for Hospitalization
Bispecific Antibodies: The Newest Immunotherapy on the Block for RRMM
Mastering HER2 in GI Malignancies: Incorporating a Multidisciplinary Approach Into Current and Emerging Management
Kristen Ciombor, MD
James J. Harding, MD
Filippo Pietrantonio, MD
Kanwal Raghav, MD
Sodium Oxybate in the Management of Narcolepsy: One Molecule, Three Formulations – and the Critical Role of Shared Decision-Making in Its Use
Clete A. Kushida, MD, PhD
Michael J. Thorpy, MD
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education